Skip to main content
Watch Insiders
Market intelligence
HEPAHealthcare

Hepion Pharmaceuticals Inc insider activity

In the last 90 days, 4 corporate insiders purchased $400,000 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$400,000
Corporate buyers
4
Latest transaction
Apr 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Apr 21, 2026Michael J. PurcellCorporate insiderOpen Market Purchase1,250,000$0.04$50,000
Apr 21, 2026Vincent S LoPrioreExecutive ChairmanOpen Market Purchase6,250,000$0.04$250,000
Apr 21, 2026Sireesh AppajosyulaCorporate insiderOpen Market Purchase1,250,000$0.04$50,000
Subscribe to see more data